Roth Capital Starts Apricus Biosciences (APRI) at Buy
Tweet Send to a FriendGet Alerts APRI Hot Sheet
Price: $2.58 -2.64%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade APRI Now!
Roth Capital initiates coverage on Apricus Biosciences (NASDAQ: APRI) with a Buy.
For an analyst ratings summary and ratings history on Apricus Biosciences click here. For more ratings news on Apricus Biosciences click here.
Shares of Apricus Biosciences closed at $2.49 yesterday, with a 52 week range of $2.34-$5.94.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Apricus Biosciences click here. For more ratings news on Apricus Biosciences click here.
Shares of Apricus Biosciences closed at $2.49 yesterday, with a 52 week range of $2.34-$5.94.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Apricus Bio (APRI) Prices 6M Common Stock Offering
- Apricus Biosciences Prices $17.1 Million Public Offering of Common Stock and Warrants
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
